DTLGX
Price
$43.16
Change
+$0.46 (+1.08%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

DTLGX vs VIGIX

Header iconDTLGX vs VIGIX Comparison
Open Charts DTLGX vs VIGIXBanner chart's image
Wilshire Large Company Growth Invmt
Price$43.16
Change+$0.46 (+1.08%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
DTLGX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DTLGX vs. VIGIX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTLGX is a StrongBuy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. DTLGX (257M). VIGIX pays higher dividends than DTLGX: VIGIX (0.53) vs DTLGX (0.08). DTLGX was incepted earlier than VIGIX: DTLGX (32 years) vs VIGIX (27 years). DTLGX is a more actively managed with annual turnover of: 66.00 vs. VIGIX (5.00). DTLGX has a lower initial minimum investment than VIGIX: DTLGX (250000) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 34.37 vs. DTLGX (22.30). VIGIX return over 5 years is better than : 129.76 vs. DTLGX (11.13).
DTLGXVIGIXDTLGX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years27 years-
Gain YTD22.02434.27264%
Front LoadN/AN/A-
Min. Initial Investment25000050000005%
Min. Initial Investment IRAN/AN/A-
Net Assets257M282B0%
Annual Yield % from dividends0.080.5314%
Returns for 1 year22.3034.3765%
Returns for 3 years-0.4732.77-1%
Returns for 5 years11.13129.769%
Returns for 10 years11.12298.584%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology